Eupraxia Pharmaceuticals Stock Alpha and Beta Analysis
| EPRX Stock | CAD 8.63 0.23 2.60% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Eupraxia Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Eupraxia Pharmaceuticals over a specified time horizon. Remember, high Eupraxia Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Eupraxia Pharmaceuticals' market risk premium analysis include:
Beta 0.67 | Alpha 0.22 | Risk 4.09 | Sharpe Ratio 0.0849 | Expected Return 0.35 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Eupraxia |
Eupraxia Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Eupraxia Pharmaceuticals market risk premium is the additional return an investor will receive from holding Eupraxia Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Eupraxia Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Eupraxia Pharmaceuticals' performance over market.| α | 0.22 | β | 0.67 |
Eupraxia Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Eupraxia Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Eupraxia Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Eupraxia Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Eupraxia Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eupraxia Pharmaceuticals shares will generate the highest return on investment. By understating and applying Eupraxia Pharmaceuticals stock market price indicators, traders can identify Eupraxia Pharmaceuticals position entry and exit signals to maximize returns.
Eupraxia Pharmaceuticals Return and Market Media
The median price of Eupraxia Pharmaceuticals for the period between Mon, Sep 15, 2025 and Sun, Dec 14, 2025 is 8.28 with a coefficient of variation of 6.28. The daily time series for the period is distributed with a sample standard deviation of 0.52, arithmetic mean of 8.29, and mean deviation of 0.42. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Using flow based indicators on Eupraxia Pharmaceuticals Inc. - Weekly Volume Report Smart Money Movement Alerts - newser.com | 10/15/2025 |
2 | Eupraxia Pharmaceuticals Expected to Announce Earnings on Thursday - MarketBeat | 10/31/2025 |
3 | Why Eupraxia Pharmaceuticals Inc. stock is trending among retail traders - Trade Risk Report Community Verified Swing Trade Signals - newser.com | 11/03/2025 |
4 | Will Eupraxia Pharmaceuticals Inc. stock outperform global peers - Weekly Risk Summary Weekly High Potential Stock Alerts - newser.com | 11/06/2025 |
5 | Volatility clustering patterns for Eupraxia Pharmaceuticals Inc. - Market Sentiment Report Reliable Price Action Trade Plans - newser.com | 11/11/2025 |
6 | Will Eupraxia Pharmaceuticals Inc. stock attract ESG investors - 2025 EndofYear Setup Real-Time Volume Spike Alerts - Fundao Cultural do Par | 11/14/2025 |
7 | Is Eupraxia Pharmaceuticals Inc. stock good for long term investing - Trade Volume Report Capital Protection Trade Alerts - newser.com | 11/17/2025 |
8 | Will Eupraxia Pharmaceuticals Inc. stock reach Wall Street targets - Market Sentiment Summary Long-Term Growth Stock Strategies - B NI V | 11/26/2025 |
9 | Scotia Capital Inc. Reduces Stake in Eupraxia Pharmaceuticals Inc. EPRX - MarketBeat | 12/01/2025 |
10 | CapEx per share of Eupraxia Pharmaceuticals Inc Warrant 2021-09.03.2026 on Eupraxia Pharma Rg TSXEPRX.WT - TradingView | 12/05/2025 |
About Eupraxia Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Eupraxia or other stocks. Alpha measures the amount that position in Eupraxia Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Eupraxia Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Eupraxia Pharmaceuticals' short interest history, or implied volatility extrapolated from Eupraxia Pharmaceuticals options trading.
Build Portfolio with Eupraxia Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in Eupraxia Stock
Eupraxia Pharmaceuticals financial ratios help investors to determine whether Eupraxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eupraxia with respect to the benefits of owning Eupraxia Pharmaceuticals security.